Clicky

COMPASS Pathways Plc(CMPS) News

Date Title
Jun 29 This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip?
Jun 27 Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
Jun 24 Compass’ stock slips despite psilocybin trial hitting target
Jun 23 Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial
Jun 23 Compass’ big psychedelic study doesn’t impress investors
Jun 23 Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
Jun 19 Trump Trade: President said to weigh possible U.S. strike against Iran
Jun 19 Psychedelic advocates hopeful Trump administration will support space, STAT says
Jun 18 Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Mar 1 COMPASS Pathways plc (CMPS): Among the Best Psychedelic Stocks to Buy in 2025
Feb 28 Psychedelic: GH Research, Compass Pathways report earnings results
Feb 28 Compass Pathways PLC (CMPS) Q4 2024 Earnings Call Highlights: Strategic Financing and R&D ...
Feb 27 Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript
Feb 27 Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
Feb 25 Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
Feb 13 It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care
Aug 28 Compass Pathways to participate in three investor conferences in September
Aug 25 Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks
Aug 1 Compass Pathways announces second quarter 2024 financial results and business highlights
Jul 28 Weekly Roundup on the Cannabis Sector & Psychedelic Sector